Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 13, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

Parenchymal post-irradiation angiosarcoma: a case report.

Zeljko Soldić1, Daniela Salopek, Marijana Jazvić

  • 1University Department of Oncology and Nuclear Medicine, Sestre Milosrdnice University Hospital, Zagreb, Croatia.

Acta Clinica Croatica
|April 22, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Correlation Between the Presence of <i>BRAF<sup>V600E</sup></i> and <i>TERT</i> Promoter Mutation and the Response to Treatment with Iodine 131 in Differentiated Thyroid Cancer Patients.

Genes·2026
Same author

Long-Term Remission in Stage IIIb Melanoma After Surgical Resection Alone: An Uncommon Clinical Scenario.

Acta dermatovenerologica Croatica : ADC·2026
Same author

Histological activity predicts relapse in pediatric ulcerative colitis despite mucosal healing: a multicenter study from the pediatric IBD Porto group of ESPGHAN.

Journal of Crohn's & colitis·2026
Same author

Immune-Mediated Colitis Induced by Immune Checkpoint Inhibitors: Pathophysiology, Clinical Management, and the Emerging Role of Fecal Microbiota Transplantation.

Biomedicines·2026
Same author

Gender equity and career progression among Croatian oncology professionals compared with the ESMO global survey.

BMC health services research·2025
Same author

ENDONASAL LEISHMANIASIS IN A FROZEN SECTION BIOPSY SPECIMEN.

Acta clinica Croatica·2025

Secondary angiosarcoma, a rare breast cancer complication, can arise after conserving therapy and radiotherapy. Early diagnosis requires high clinical suspicion due to misleading symptoms and negative initial tests.

Area of Science:

  • Oncology
  • Radiotherapy
  • Surgical Oncology

Background:

  • Secondary angiosarcoma is an aggressive malignancy complicating breast cancer treatment.
  • It can develop after breast-conserving surgery and radiotherapy.
  • Early symptoms are often subtle and diagnostic tests like mammography and fine-needle aspiration (FNA) may be negative.

Observation:

  • A case study of a patient with secondary angiosarcoma involving breast parenchyma is presented.
  • The patient had a history of quadrantectomy and radiotherapy for early-stage breast carcinoma (T1cN1Mx).
  • Clinical presentation mimicked benign conditions, delaying diagnosis.

Findings:

  • Angiosarcoma diagnosis in this case was challenging due to non-specific clinical signs.
  • Mammography and FNA provided inconclusive results in the early stages.

Related Experiment Videos

Last Updated: Jun 13, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

  • Histopathological examination confirmed the diagnosis of angiosarcoma.

    • Implications:

    • Highlights the importance of maintaining a high index of clinical suspicion for secondary angiosarcoma in patients with a history of breast cancer treatment.
    • Suggests the need for advanced imaging or biopsy in suspicious cases, even with negative initial results.
    • Emphasizes the aggressive nature of the tumor and the need for timely and appropriate management strategies.